Xylem Inc: Argus Research cuts to hold from buy
XYL•Argus Research cut its rating on Xylem Inc to hold from buy.
Related News
Labcorp completes acquisition of Millennium Health
LH•
Diamondback Energy target price raised to $260 from $256 by UBS
FANG•
Graphic Packaging to present at Baird Global Industrial Conference
GPK•
Henry Schein target price raised to $95 from $94
HSIC•
Freshworks: UBS raises target price to $17 from $14
FRSH•